September 11, 2025

[Progress on biologic therapies for severe asthma].

View Full Paper

Ask AI

Bookmark

Biologics improve treatment outcomes for severe asthma patients, targeting specific inflammatory pathways.
Approved agents include Omalizumab, Mepolizumab, and others, effectively managing symptoms in uncontrolled cases.
This review categorizes biologics by their targets and details ongoing clinical investigations into new therapies.
Future trends in biologic therapies focus on overcoming current challenges in treatment implementation.

Discussion

No takes yet. Share an insight, caveat, or question.

This review demonstrates the role of biologics in asthma management, highlighting their targets and implications for treatment.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark